What happened
Biopharma name Regeneron Pharmaceuticals (NASDAQ:REGN) rallied 11.2% in June, according to data from S&P Global Market Intelligence. A series of encouraging drug-development updates kept the recovery rally going.
So what
A multi-month pullback…

Click here to view the original article.